Every batch is HPLC-tested to confirm a purity of 99%, consistent with its GLP-1/GIP/GCGR triple-agonist profile (CAS number 2381089-83-2)
This GLP-1 is naturally found in the body
Continue current treatment and monitor results through the second half of 2026 TRIUMPH-2 data will clarify whether a switch in 2028 makes clinical sense for your situation
Do not use lotions, creams, or serums on the area before application they interfere with the adhesive and reduce absorption
Whilst there is no confirmed causal link between retatrutide and depression, certain individuals may be more vulnerable to mood changes during any significant pharmacological intervention, particularly one that produces rapid and substantial weight loss
This has led some researchers to target 9mg rather than 12mg as their maintenance dose, especially given that the difference (2.3 percentage points) may not justify the additional side effect burden for all individuals